In addition, in those clinical breast invasive carcinoma samples with the amplified genomic region, there are statistically significant differences (p value calculations by Wilcoxon rank sum test) in mRNA expression level among different copy number alteration levels for ERBB2 and GRB7, respectively (Figure 5). This evidence concerns the gene ERBB2 and invasive breast carcinoma.